Inactivation of C5a Anaphylatoxin by a Peptide That Is Complementary to a Region of C5a

Journal of Immunology

Volumn 172, Issue 10, 2004, Pages 6382-6387

  Fujita, Emiko ^a   Farkas, Imre ^a,c   Campbell, William ^b   Baranyi, Lajos ^b   Okada, Hidechika ^b   Okada, Noriko ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLSERYLGLYCYLALANYLPROLYLALANYLPROLYLGLYCYLPROLYLALANYLGLYCYLPROLYLLEUC YLARGINYLPROLYLMETHIONYLPHENYLALANINE; ALANYLSERYLTHREONYLALANYLPROLYLALANYLARGINYLALANYLGLYCYLLEUCYLPROLYLARGINYL LEUCYLPROLYLLYSYLPHENYLALANYLPHENYLALANINE; ANAPHYLATOXIN; CALCIUM ION; COMPLEMENT COMPONENT C5A; PEPTIDE; PROTEIN PL37; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CALCIUM MOBILIZATION; CALCIUM SIGNALING; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MALE; NEUTROPHIL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

EID: 2442487762     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.10.6382     Document Type: Article

References (20)

1. Ember, J. A., and T. E. Hugli. 1997. Complement factors and their receptors. Immunopharmacology 38:3.
2. Gerard, C., and N. P. Gerard. 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775.
3. Sumichika, H., K. Sakata, S., Takeshita, S. Ishibuchi, M. Nakamura, T. Kamahori, S. Ehara, K. Itoh, T. Ohtsuka, T. Ohbora, et al. 2002. Identification of a potent and orally active non-peptide C5a receptor antagonist. J. Biol. Chem. 277:49403.
4. Michael, K. 2001. Targeting complement in therapy. Immunol. Rev. 180:177.
5. Baranyi, L., W. Campbell, K. Ohshima, S. Fujimoto, M. Boros, and H. Okada. 1995. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat. Med. 1:894.
6. Baranyi, L., W. Campbell, and H. Okada. 1996. Antisense homology boxes in C5a receptor and C5a anaphylatoxin. J. Immunol. 157:4591.
7. Farkas, I., L. Baranyi, Z. S. Liposits, T. Yamamoto, and H. Okada. 1998. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience 86:903.
8. Campbell, W., L. Kleiman, L. Baranyi, Z. Li, A. Khorchid, E. Fujita, N. Okada, and H. Okada. 2002. A novel genetic algorithm for designing mimetic peptides that interfere with the function of a target molecule. Microbiol. Immunol. 46:211.
9. Shimomura, Y., T. Kawamura, H. Koura, W. Campbell, N. Okada, and H. Okada. 2003. Modulation of procarboxypeptidase R (proCPR) activation by complementary peptides to thrombomodulin. Microbiol. Immunol. 47:241.
10. Takizawa, H., N. Okada, and H. Okada. 1994. Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J. Immunol. 152:3032.
11. Matsuo, S., S. Ichida, H. Takizawa, N. Okada, L. Baranyi, A. Iguchi, B. P. Morgan, and H. Okada. 1994. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J. Exp. Med. 180:1619.
12. Mizuno, M., K. Nishikawa, N. Okada, S. Matsuo, K. Ito, and H. Okada. 1999. Inhibition of a membrane complement regulatory protein by a monoclonal antibody induces acute lethal shock in rats primed with lipopolysaccharide. J. Immunol. 162:5477.
13. Konteatis, Z. D., S. J. Siciliano, G. Van Riper, C. J. Molineaux, S. Pandya, P. Fischer, H. Rosen, R. A. Mumford, and M. S. Springer. 1994. Development of C5a receptor antagonists: differential loss of functional responses. J. Immunol. 153:4200.
14. Kondo, C., M. Mizuno, K. Nishikawa, Y. Yuzawa, and S. Matsuo. 2001. The role of C5a in the development of thrombotic glomerulonephritis in rats. Clin. Exp. Immunol. 124:323.
15. Pellas, T. C., W. Boyar, J. van Oostrum, J. Wasvary, L. R. Fryer, G. Pastor, M. Sills, A. Braunwalder, D. R. Yarwood, R. Kramer, et al. 1998. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo. J. Immunol. 160:5616.
16. Stevens, J. H., P. O'Hanley, J. M. Shapiro, F. G. Mihm, P. S. Satoh, I. A. Collins, and T. A. Raffin. 1986. Effects of anti-C5a antibodies on the adult's respiratory distress syndrome in septic primates. J. Clin. Invest. 77:1812.
17. Hatherill, J. R., K. E. Stephens K. Nagao, A. Ishizaka, L. Wilmarth, J. C. Wang, T. Deinhart, J. W. Larrick, and T. A. Raffin. 1989. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release. J. Biol. Response Mod. 8:614.
18. Czermak, B. J., V. Sarma, C. L. Pierson, R. L. Warner, M. Huber-Lang, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. Protective effects of C5a blockade in sepsis. Nat. Med. 5:788.
19. Mollison, K. W., W. Mandecki, E. R. Zuiderweg, T. A. Fey, R. A. Krause, R. G. Conway, L. Miller, R. P. Edalji, and M. A. Shallcross. 1989. Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutaganesis. Proc. Natl. Acad. Sci. USA 86:292.
20. Kawai, M., D. A. Quincy, B. Lane, K. W. Mollison, J. R. Luly, and G. W. Carter. 1991. Identification and synthesis of a receptor binding site of human anaphylatoxin C5a. J. Med. Chem. 34:2068.